FrancophonIA/ELRC3.0 huggingface dataset:
English: Cetirizine was poorly cleared by haemodialysis.
Estonian: Tsetirisiin oli hemodialüüsi teel halvasti eemaldatav.
English: Amber glass bottle (type III) with 10, 15, 20, or 30 ml solution, fitted with a dropper insert in white low density polyethylene and closed with a white polypropylene child-resistant closure.
Estonian: 10, 15, 20 või 30 ml lahusega pruun klaaspudel (tüüp III), valge polüetüleenist tilgutiga ja suletud valge lastekindla polüpropüleenkorgiga.
English: - Body as a whole: common: fatigue
Estonian: Organism tervikuna Sage: väsimus
English: Children between 6 and 12 years old:
Estonian: 6…12-aastased lapsed:
English: QUALITATIVE AND QUANTITATIVE COMPOSITION One film-coated tablets contains 10 mg cetirizine dihydrochloride Excipients: one film-coated tablet contains 66.40 mg lactose-monohydrate For a full list of excipients, see section 6.1
Estonian: KVALITATIIVNE JA KVANTITATIIVNE KOOSTIS Üks õhukese polümeerikattega tablett sisaldab 10 mg tsetirisiindivesinikkloriidi Abiained: üks õhukese polümeerikattega tablett sisaldab 66,40 mg laktoosmonohüdraati Abiainete täielik loetelu vt lõik 6.1.
English: White, oblong, film-coated tablet, with breakline and Y-Y logo
Estonian: Valge, piklik, õhukese polümeerikattega tablett, millel on poolitusjoon ja Y-Y logo
English: PHARMACEUTICAL FORM Oral drops, solution Clear and colorless liquid
Estonian: RAVIMVORM Suukaudsed tilgad, lahus Selge ja värvitu vedelik
English: If you think you have any side effects not mentioned in this leaflet, please inform your doctor or pharmacist.
Estonian: Kui te märkate mõnda kõrvaltoimet, mida selles infolehes ei ole nimetatud, palun rääkige sellest oma arstile või apteekrile.
English: From this pooling, the following adverse events were reported for cetirizine 10 mg in the placebocontrolled trials at rates of 1.0 % or greater:
Estonian: Tsetirisiini 10 mg annuse kasutamisel platseebo-kontrolliga uuringutes kirjeldati sellest kombinatsioonist järgmiste kõrvaltoimete teket sagedusega 1,0% või enam:
English: Body as a whole - general disorders Fatigue
Estonian: Organism tervikuna - üldised häired Väsimus
English: Spain: Alerlisin, Virlix, Reactine 5mg/5ml solución oral, Zyrtec solución oral Sweden: Zyrlex
Estonian: Hispaania: Alerlisin, Virlix, Reactine 5mg/5ml solución oral, Zyrtec solución oral Rootsi: Zyrlex
English: - Colloidal anhydrous silica - Magnesium stearate - Opadry Y-1-7000 - Hydroxypropylmethylcellulose (E 464) - Titanium dioxide (E 171) - Macrogol 400
Estonian: 6.1 Abiainete loetelu - Mikrokristalne tselluloos - Laktoos - Kolloidne veevaba räni - Magneesiumstearaat - Opadry Y-1-7000 - Hüdroksüpropüülmetüültselluloos (E 464) - Titaandioksiid (E 171) - Makrogool 400
English: Since cetirizine is mainly eliminated via renal route (see section 5.2), in cases no alternative treatment can be used, the dosing intervals must be individualized according to renal function.
Estonian: Kuna tsetirisiin eritub peamiselt neerude kaudu (vt lõik 5.2), tuleb alternatiivse ravimeetodi puudumisel annustamine kohandada individuaalselt, arvestades neerufunktsiooni.
English: The use of the product is not recommended in infants and toddlers aged less than 2 years.
Estonian: Ravimit ei soovitata kasutada alla 2-aastastel imikutel ja väikelastel.
English: • Cetrizine is indicated for the relief of chronic idiopathic urticaria.
Estonian: • Tsetirisiin on näidustatud kroonilise idiopaatilise urtikaaria leevendamiseks.
English: 5 mg once every 2 days
Estonian: 5 mg üks kord päevas iga 2 päeva järel
English: Walton Oaks Dorking Road, Walton on the Hill KT 20 7 NS, Surrey Great Britain
Estonian: Pfizer Consumer Healthcare (GB) Walton Oaks Dorking Road, Walton on the Hill KT 20 7 NS, Surrey Great Britain
English: What Zyrtec contains - The active substance of Zyrtec is cetirizine dihydrochloride.
Estonian: Mida Zyrtec sisaldab - Ravimi Zyrtec toimeaine on tsetirisiindivesinikkloriid.
English: Ireland: Zirtek oral solution 1mg/ml
Estonian: Iirimaa: Zirtek oral solution 1mg/ml
English: The doses proposed for registration have been demonstrated as being safe and effective in many trials performed in children 2 to 12 years old, as reviewed in the clinical expert report provided in the MAH dossier.
Estonian: Paljudes 2-12-aastastel lastel tehtud uuringutes, mida käsitletakse müügiloa hoidja toimikus sisalduvas kliinilises ekspertaruandes, on tõendatud registreerimiseks soovitatud annuste ohutust ja tõhusust.
English: Following side effects have been reported in post marketing experience.
Estonian: Turustamisjärgse kogemuse põhjal on kirjeldatud järgmisi kõrvaltoimeid.
English: Important information about some of the ingredients of Zyrtec Zyrtec film-coated tablets contain lactose; if you have been told by your doctor that you have an intolerance to some sugars, please contact your doctor before taking this medicinal product.
Estonian: Oluline teave mõningate ravimi Zyrtec koostisainete suhtes Zyrtec suukaudne lahus sisaldab sorbitooli; kui arst on teile öelnud, et te ei talu teatud suhkruid, peate te enne ravimi kasutamist konsulteerima arstiga.
English: Taking Zyrtec with food and drink Food does not affect noticeabily the absorption of cetirizine.
Estonian: Ravimi Zyrtec kasutamine koos toidu ja joogiga Toit ei mõjuta oluliselt tsetirisiini imendumise määra.
English: Slovak Republic: Zyrtec gtt por 10mg/ml Slovenia: Zyrtec10 mg/ml peroralne kapljice, raztopina Spain: Alerlisin, Virdos, Zyrtec gotas orales en solución Sweden: Zyrlex
Estonian: Slovakkia: Zyrtec gtt por 10mg/ml Sloveenia: Zyrtec10 mg/ml peroralne kapljice, raztopina Hispaania: Alerlisin, Virdos, Zyrtec gotas orales en solución Rootsi: Zyrlex
English: Germany: Zyrtec saft
Estonian: Saksamaa: Zyrtec saft
English: - Nervous system disorders:
Estonian: Närvisüsteemi häired:
English: Italy: Formistin, Virlix, Zirtec 10mg/ml gocce orali soluzione Latvia: Zyrtec
Estonian: Itaalia: Formistin, Virlix, Zirtec 10mg/ml gocce orali soluzione Läti: Zyrtec
English: Caution in epileptic patients and patients at risk of convulsions is recommended.
Estonian: Epilepsia ja krambiohuga patsientidel on soovitatav ravimit kasutada ettevaatusega.
English: Rare: hypersensitivity Very rare: anaphylactic shock
Estonian: Harv: ülitundlikkus Väga harv: anafülaktiline šokk
English: - Blood and lymphatic disorders: very rare: thrombocytopenia (low levels of blood platelets)
Estonian: Vere ja lümfisüsteemi häired Väga harv: trombotsütopeenia (vereliistakute madal tase)
English: Amber glass bottle (type III) of 60, 75, 100, 125, 150, or 200 ml, closed with a white polypropylene child-resistant closure.
Estonian: 60, 75, 100, 125, 150 või 200 ml pruun klaaspudel (tüüp III), suletud lastekindla valge polüpropüleenkorgiga.
English: Italy: Zirtec 1mg/ml soluzione orale
Estonian: Itaalia: Zirtec 1mg/ml soluzione orale
English: - You must contact a doctor if your symptoms worsen or do not improve after 3 days.
Estonian: - Kui pärast 3 päeva möödumist haigussümptomid süvenevad ega leevendu, peate oma arstiga ühendust võtma.
English: The drops should be poured in a spoon or diluted in water, and taken orally.
Estonian: Manustamiseks valada tilgad lusikale või lahjendada vähese veega.
English: Hungary: Zyrtec oldat
Estonian: Ungari: Zyrtec oldat
English: Elderly: Following a single 10 mg oral dose, half-life increased by about 50 % and clearance decreased by 40 % in 16 elderly subjects compared to the normal subjects.
Estonian: Eakad: ühekordse 10 mg suukaudse annuse manustamise järel suurenes 16 eakal isikul teiste inimestega võrreldes poolväärtusaeg umbes 50% ning kliirens langes 40%.
English: Patients with moderate renal impairment had a 3-fold increase in half-life and 70 % decrease in clearance compared to healthy volunteers.
Estonian: Mõõduka neerukahjustusega patsientidel tõusis tervete vabatahtlikega võrreldes poolväärtusaeg 3 korda ning kliirens langes 70%.
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS PVC/ALUMINIUM BLISTERS
Estonian: MINIMAALSED NÕUDED, MIS PEAVAD OLEMA KIRJAS BLISTER- VÕI RIBAPAKENDIL
English: Caution should be exercised when prescribing to pregnant or breast feeding women because cetirizine passes into breast milk.
Estonian: Raseduse või imetamise ajal tuleb ravimit kasutada ettevaatusega, kuna tsetirisiin eritub rinnapiima.
English: Hepatically impaired patients: Patients with chronic liver diseases (hepatocellular, cholestatic, and biliary cirrhosis) given 10 or 20 mg of cetirizine as a single dose had a 50 % increase in half-life along with a 40 % decrease in clearance compared to healthy subjects.
Estonian: Maksakahjustusega patsiendid: kroonilise maksahaigusega (hepatotsellulaarne, kolestaatiline ja biliaarne tsirroos) patsientidel, kes said 10 või 20 mg tsetirisiini ühekordse annusena tõusis tervete isikutega võrreldes poolväärtusaeg 50% ning kliirens langes 40%.
English: One drop contains 0.5 mg of cetirizine dihydrochloride.
Estonian: Üks tilk sisaldab 0,5 mg tsetirisiindivesinikkloriidi.
English: 21 tablets
Estonian: 21 tabletti
English: Invented name
Estonian: Ravimi väljamõeldud nimetus Nimi
English: In these sensitive patients, concurrent use with alcohol or other CNS depressants may cause additional reductions in alertness and impairment of performance.
Estonian: Ravimi samaaegne manustamine alkoholi või teiste kesknärvisüsteemi pidurdavate ainetega võib tundlikel patsientidel põhjustada täiendavat tähelepanu langust ja reaktsioonihäireid.
English: Adverse drug reactions at rates of 1 % or greater in children aged from 6 months to 12 years, included in placebo-controlled clinical or pharmacoclinical trials are:
Estonian: 6-kuustel…12-aastastel lastel läbiviidud platseebo-kontrolliga kliinilistes või farmakokliinilistes uuringutes ilmnenud kõrvaltoimed esinemissagedusega ≥1% olid järgmised:
English: At therapeutic doses, no clinically significant interactions have been demonstrated with alcohol (for a blood alcohol level of 0.5 g/l).
Estonian: Raviannustes ei ole kliiniliselt olulisi koostoimeid alkoholiga täheldatud (alkoholi sisaldus veres 0,5 g/l).
English: In pediatric patients suffering from renal impairment, the dose will have to be adjusted on an individual basis taking into account the renal clearance of the patient, his age and his body weight.
Estonian: Neerukahjustusega lastel tuleb annust kohandada individuaalselt, arvestades patsiendi renaalset kliirensit, vanust ja kehakaalu.
English: Due to the profile of cetirizine, no interactions with other drugs are expected.
Estonian: Tsetirisiinil ei esine koostoimeid teiste ravimitega.
English: Austria: Zyrtec 10 mg/ml -Tropfen Belgium: Cetirizine-UCB, Zyrtec, Virlix Bulgaria: Zyrtec
Estonian: Austria: Zyrtec 10 mg/ml -Tropfen Belgia: Cetirizine-UCB, Zyrtec, Virlix Bulgaaria: Zyrtec
English: Regarding the dosing by weight, the MAH responded that systemic exposure to cetirizine is not only a function of body weight but also of renal clearance of the drug, with studies demonstrating that clearance is more important when age is low.
Estonian: Kehakaalu alusel annustamise kohta vastas müügiloa hoidja, et süsteemne kokkupuude tsetirisiiniga ei ole ainult kehakaalu, vaid ka ravimi renaalse kliirensi funktsioon.
English: For these less frequently reported undesirable effects, the estimated frequencies (uncommon: ≥1/1,000 to 1/100, rare: ≥1/10,000 to 1/1,000, very rare: 1/10,000) are made based on post-marketing experience.
Estonian: Harvem esinevate kõrvaltoimete näitajad (aeg-ajalt: ≥1/1000 kuni <1/100, harv: ≥1/10 000 kuni <1/1000, väga harv: < 1/10 000) baseeruvad turustusjärgsel kogemusel.
English: Methyl parahydroxybenzoate and propyl parahydroxybenzoate may cause allergic reactions (possibly delayed).
Estonian: Metüülparahüdroksübensoaat ja propüülparahüdroksübensoaat võivad tekitada allergilisi reaktsioone (ka hilistüüpi).
English: 10 mg once daily
Estonian: 10 mg üks kord päevas
English: Hepatobiliary disorders: Rare: hepatic function abnormal (increased transaminases, alkaline phosphatase, γ-GT and bilirubin)
Estonian: Harv: maksafunktsioonihäired (transaminaaside, alkaalse fosfataasi, gamma-GT ja bilirubiini väärtuste suurenemine)
English: Hungary: Zyrtec filmtabletta, Zyrtec start filmtabletta Ireland: Zirtek tablets
Estonian: Ungari: Zyrtec filmtabletta, Zyrtec start filmtabletta
English: - The other ingredients are sorbitol (E 420), glycerol, propylene glycol, saccharine sodium, methyl (4-hydroxybenzoate) / propyl (4-hydroxybenzoate) = E 218 / E 216, flavouring agent, sodium acetate, acetic acid, purified water.
Estonian: - Teised abiained on sorbitool (E 420), glütserool, propüleenglükool, naatriumsahhariin, metüül-4-hüdroksübensoaat / propüül-4-hüdroksübensoaat = E 218 / E 216, maitseaine, naatriumatsetaat, äädikhape, puhastatud vesi.
English: Uncommon: paraesthesia
Estonian: Aeg-ajalt: paresteesia
English: Hungary: Zyrtec cseppek
Estonian: Ungari: Zyrtec cseppek
English: Important information about some of the ingredients of Zyrtec Zyrtec oral drops solution contain methyl (4-hydroxybenzoate) E 218 propyl (4-hydroxybenzoate) E 216 that may cause allergic reactions (possibly delayed).
Estonian: Oluline teave mõningate ravimi Zyrtec koostisainete suhtes Zyrtec suukaudsed tilgad, lahus sisaldab metüül-4-hüdroksübensoaati E 218 ja propüül-4-hüdroksübensoaati E 216, mis võivad põhjustada allergilisi reaktsioone (ka hilistüüpi).
English: Adverse events reported after an intake of at least 5 times the recommended daily dose are: confusion, diarrhoea, dizziness, fatigue, headache, malaise, mydriasis, pruritus, restlessness, sedation, somnolence, stupor, tachycardia, tremor, and urinary retention.
Estonian: Vähemalt viiekordse ettenähtud ööpäevase annuse sissevõtmise järgselt on kirjeldatud järgmisi kõrvalnähte: segasus, kõhulahtisus, pearinglus, väsimus, peavalu, halb enesetunne, müdriaas, sügelus, rahutus, uimasus, unisus, stuupor, tahhükardia, treemor ja uriinipeetus.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON BOX
Estonian: VÄLISPAKENDIL PEAVAD OLEMA JÄRGMISED ANDMED KARTONGKARP
English: Luxembourg: Virlix, Zyrtec, Cetirizine-UCB Norway: Zyrtec
Estonian: Luksemburg: Virlix, Zyrtec, Cetirizine-UCB Norra: Zyrtec
English: STATEMENT OF ACTIVE SUBSTANCE(S) 1 ml solution contain 1 mg of cetirizine dihydrochloride
Estonian: TOIMEAINE(TE) SISALDUS 1 ml lahust sisaldab 1 mg tsetirisiindivesinikkloriidi
English: Film-coated tablets 1 tablet
Estonian: Õhukese polümeerikattega tabletid 1 tablett
English: In adults, children, infants and toddlers 2 year and above:
Estonian: Täiskasvanud, lapsed ning vähemalt kaheaastased väikelapsed:
English: If you take more Zyrtec than you should If you think you have taken an overdose of Zyrtec please inform your doctor.
Estonian: Kui te võtate ravimit Zyrtec rohkem kui ette nähtud Kui te arvate, et olete võtnud ravimi Zyrtec üleannuse, teavitage sellest oma arsti.
English: Accidental use of the drug by a pregnant women should not produce any harmful effects on the foetus.
Estonian: Ravimi juhuslik kasutamine rasedatel naistel ei pruugi lootele kahjustavalt mõjuda, siiski tuleks ravimi võtmine lõpetada.
English: PACKAGE LEAFLET: INFORMATION FOR THE USER Zyrtec and associated names (see Annex I) 10 mg/ml oral drops, solution
Estonian: PAKENDI INFOLEHT: INFORMATSIOON KASUTAJALE Zyrtec ja sarnased nimetused (Vaata Lisa I)} 10 mg/ml suukaudsed tilgad, lahus [Vaata Lisa I - täidetakse riiklikult]
English: 10 ml (equals to 2 measuring spoons) contain 10 mg of cetirizine dihydrochloride.
Estonian: 10 ml (2 mõõtlusikatäit) sisaldab 10 mg tsetirisiindivesinikkloriidi.
English: - Eye disorders: very rare: accommodation disorder, blurred vision, oculogyration (eyes having uncontrolled circular movements)
Estonian: Väga harv: akommodatsioonihäired, nägemise hägustumine, okulogüratsioon (tahtele allumatu silmade pööritamine)
English: Netherlands: Reactine, Zyrtec
Estonian: Holland: Reactine, Zyrtec
English: QUALITATIVE AND QUANTITATIVE COMPOSITION One ml of solution contains 10 mg cetirizine dihydrochloride, one drop of solution contains 0.5 mg cetirizine dihydrochloride
Estonian: KVALITATIIVNE JA KVANTITATIIVNE KOOSTIS 1 ml lahust sisaldab 10 mg tsetirisiindivesinikkloriidi, 1 tilk lahust sisaldab 0,5 mg tsetirisiindivesinikkloriidi
English: ANNEX II SCIENTIFIC CONCLUSIONS AND GROUNDS FOR THE SUMMARIES OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET PRESENTED BY THE EMEA
Estonian: II LISA EUROOPA RAVIMIAMETI ESITATUD TEADUSLIKUD JÄRELDUSED NING PÕHJENDUSED RAVIMI OMADUSTE KOKKUVÕTETE, MÄRGISTUSE JA PAKENDI MUUTMISE ALUSED
English: Adverse effects such as confusion, diarrhoea, dizziness, tiredness, headache, ailing, dilating of pupil, itching, restlessness, sedation, somnolence, stupor, abnormal rapid heart rate, tremors and urinary retention have been reported.
Estonian: Kirjeldatud on järgmisi kõrvaltoimeid: segasus, kõhulahtisus, pearinglus, väsimus, peavalu, haiglaslik olek, pupillide laienemine, sügelus, rahutus, uimasus, unisus, vähene reageerimine välistele ärritajatele, südamepekslemine, värinad ja uriinipeetus.
English: MARKETING AUTHORISATION NUMBER [To be completed nationally]
Estonian: MÜÜGILOA NUMBER [Täidetakse riiklikult]
English: Dosage and frequency
Estonian: Annus ja annustamissagedus
English: Luxembourg: Reactine, Zyrtec, Cetirizine-UCB
Estonian: Luksemburg: Reactine, Zyrtec, Cetirizine-UCB
English: Rare: aggression, confusion, depression, hallucination, insomnia Very rare: tic
Estonian: Harv: agressiivsus, segasus, depressioon, hallutsinatsioonid, unetus Väga harv: tikid
English: Belgium: Reactine, Cetirizine-UCB, Zyrtec
Estonian: Belgia: Reactine, Cetirizine-UCB, Zyrtec
English: - Sorbitol solution at 70 % (non crystallizing) (E420) - Glycerol - Propylene glycol - Sodium saccharinate - Methylparahydroxybenzoate (E 218) - Propylparahydroxybenzoate (E 216) - Banana flavor 54.330/A (Firmenich) - Sodium acetate - Glacial acetic acid - Purified water
Estonian: - 70% sorbitooli lahus (mittekristalliseeruv) (E 420) - Glütserool - Propüleenglükool - Naatriumsahharinaat - Metüülparahüdroksübensoaat (E 218) - Propüülparahüdroksübensoaat (E 216) - Banaani maitseaine 54.330/A (Firmenich) - Naatriumatsetaat - Jää-äädikhape - Puhastatud vesi
English: Patients with severe renal impairment at less than 10 ml/min creatinine clearance.
Estonian: Raske neerukahjustusega patsiendid, kelle kreatiniini kliirens on <10 ml/min.
English: Norway: Reactine, Zyrtec
Estonian: Norra: Reactine, Zyrtec
English: Poland: Reactine, Virlix, Zyrtec, Zyrtec UCB
Estonian: Poola: Reactine, Virlix, Zyrtec, Zyrtec UCB
English: QUALITATIVE AND QUANTITATIVE COMPOSITION One ml of solution contains 1 mg cetirizine dihydrochloride Excipients: - one ml of solution contains 450 mg sorbitol (solution at 70 %, non crystallizing) - one ml of solution contains 1.35 mg methylparahydroxybenzoate - one ml of solution contains 0.15 mg propylparahydroxybenzoate For a full list of excipients, see section 6.1
Estonian: - 1 ml lahust sisaldab 450 mg sorbitooli (70% mittekristalliseeruv lahus) - 1 ml lahust sisaldab 1,35 mg metüülparahüdroksübensoaati - 1 ml lahust sisaldab 0,15 mg propüülparahüdroksübensoaati
English: Zyrtec oral solution contain methyl (4-hydroxybenzoate) E 218, propyl (4-hydroxybenzoate) E 216 that may cause allergic reactions (possibly delayed).
Estonian: Zyrtec suukaudne lahus sisaldab metüül-4-hüdroksübensoaati E 218, propüül-4-hüdroksübensoaati E 216, mis võivad põhjustada allergilisi reaktsioone (ka hilistüüpi).
English: 5 mg once daily
Estonian: 5 mg üks kord päevas
English: PACKAGE LEAFLET For medicinal products available on prescription
Estonian: PAKENDI INFOLEHT Retseptiravim
English: Do not take Zyrtec - if you have a severe kidney disease (severe renal failure with creatinine clearance below 10 ml/min); - if you are known to be hypersensitive to the active substance of Zyrtec, to any of its excipients (other constituents), to hydroxyzine or to any piperazine derivatives (closely related active substances of other medicines).
Estonian: Ärge võtke ravimit Zyrtec kui teil on raske neeruhaigus (raske neerupuudulikkus kreatiniini kliirensiga alla 10 ml/min); kui olete ülitundlik ravimi Zyrtec toimeaine suhtes, mistahes abiaine (teise koostisaine), hüdroksüsiini või piperasiini derivaadi (teise ravimi sarnane toimeaine) suhtes.
English: Actually, neither pharmacodynamic nor significant pharmacokinetic interaction was reported in drug-drug interactions studies performed, notably with pseudoephedrine or theophylline (400 mg/day).
Estonian: Pseudoefedriini või teofülliini (400 mg/päevas) koostoime uuringus ei täheldatud farmakodünaamilist ega olulist farmakokineetilist koostoimet.
English: Denmark: Benaday, Zyrtec
Estonian: Taani: Benaday, Zyrtec
English: You should not take Zyrtec during breast feeding because cetirizine passes into breast milk.
Estonian: Ravimi Zyrtec kasutamine rinnaga toitmise ajal on vastunäidustatud, sest tsetirisiin eritub rinnapiima.
English: 4 tablets
Estonian: 4 tabletti
English: France: Virlix, Zyrtec
Estonian: Prantsusmaa: Virlix, Zyrtec
English: In adults and children 2 year and above:
Estonian: Täiskasvanud ja lapsed alates 2. eluaastast:
English: Poland: Virlix, Zyrtec
Estonian: Poola: Virlix, Zyrtec
English: Children between 2 and 6 years old
Estonian: 2…6-aastased lapsed:
English: 45 tablets
Estonian: 45 tabletti
English: 5 mg twice daily as 10 drops twice daily.
Estonian: 5 mg (10 tilka) kaks korda päevas.
English: The steady - state peak plasma concentrations is approximately 300 ng/ml and is achieved within 1.0 ± 0.5 h. No accumulation is observed for cetirizine following daily doses of 10 mg for 10 days.
Estonian: Maksimaalne plasma tasakaalukontsentratsioon on umbes 300 ng/ml ning see saabub 1,0 ± 0,5 tunni jooksul.
English: 5 tablets
Estonian: 5 tabletti
English: Zyrtec 1 mg/mlorale Lösung oral solution
Estonian: Zyrtec 1 mg/mlorale Lösung
English: Blood and lymphatic disorders: Very rare: thrombocytopenia
Estonian: Vere- ja lümfisüsteemi häired: Väga harv: trombotsütopeenia
English: 10 mg cetirizine dihydrochloride.
Estonian: lahus sisaldab 10 mg tsetirisiindivesinikkloriidi.
English: - Renal and urinary disorders: very rare: abnormal elimination of urine
Estonian: Neerude ja kuseteede häired Väga harv: uriini eritumise häired
English: • Adults and adolescents over 12 years of age: 10 mg once daily (20 drops).
Estonian: • Täiskasvanud ja üle 12-aastased noorukid: 10 mg üks kord päevas (20 tilka).
English: Contains methylparahydroxybenzoate (E 218), propylparahydroxybenzoate (E 216), sorbitol (E 420), among other substances.
Estonian: Muude abiainete hulgas sisaldab metüülparahüdroksübensoaati (E 218), propüülparahüdroksübensoaati (E 216), sorbitooli (E 420).
English: 40 tablets
Estonian: 40 tabletti
English: If you develop one of the side effects described above, please inform your doctor.
Estonian: Kui teil tekib mõni ülalnimetatud kõrvaltoimetest, teavitage sellest oma arsti.
English: One ml of solution contains 10 mg of cetirizine dihydrochloride, one drop of solution contains 0.5 mg cetirizine dihydrochloride
Estonian: 1 ml lahust sisaldab 10 mg tsetirisiindivesinikkloriidi, 1 tilk lahust sisaldab 0,5 mg tsetirisiindivesinikkloriidi.
English: - Cardiac disorders: rare: tachycardia (heart beating too fast)
Estonian: Südame häired Harv: tahhükardia (südamepekslemine)
English: 15 tablets
Estonian: 15 tabletti
English: Finland: Benaday, Zyrtec
Estonian: Soome: Benaday, Zyrtec
English: Take special care with Zyrtec
Estonian: Eriline ettevaatus on vajalik ravimiga Zyrtec
English: Respiratory system disorders Rhinitis
Estonian: Respiratoorsed häired Riniit
English: common: dizziness, headache uncommon: paresthesia (abnormal feelings of the skin) rare: convulsions, movements disorders very rare: syncope, tremor, dysgeusia (altered taste)
Estonian: Aeg-ajalt: paresteesia (nahatundlikkuse häire) Harv: krambid, liigutuste häired Väga harv: minestamine, treemor, düsgeuusia (maitsemuutus)
English: Do not take Zyrtec - if you have a severe kidney disease (severe renal failure with creatinine clearance below 10 ml/min); - if you are known to be hypersensitive to the active substance of Zyrtec, to any of its excipients
Estonian: Ärge kasutage ravimit Zyrtec - kui teil on raske neeruhaigus (raske neerupuudulikkus kreatiniini kliirensiga alla 10 ml/min) - kui olete allergiline (ülitundlik) ravimi Zyrtec toimeaine suhtes, mistahes abiaine (teise koostisaine),